Task: Answer the multiple choice question.
Query: Which drug exhibits a 5.660\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCC(Cc1ccccc1)NC(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
(b) Cc1ccc(S(=O)(=O)N2CCC(C(=O)N3CC(C)OC(C)C3)CC2)cc1
(c) Cc1cc(C(=O)N2CC(C)CC(C)C2)c(C)o1
Answer: a. CCC(Cc1ccccc1)NC(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(Cc1ccccc1)NC(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
CCC(Cc1ccccc1)NC(=O)CCNS(=O)(=O)c1cc(Br)cnc1N
3-[(2-amino-5-bromopyridin-3-yl)sulfonylamino]-N-(1-phenylbutan-2-yl)propanamide